Trial record 1 of 1 for:    ACNS0821
Previous Study | Return to List | Next Study

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by National Cancer Institute (NCI)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: October 7, 2010
Last updated: November 19, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2021 (Final data collection date for primary outcome measure)